Heregulin reverses the oligomerization of HER3

被引:41
作者
Landgraf, R [1 ]
Eisenberg, D [1 ]
机构
[1] Univ Calif Los Angeles, US DOE, Inst Mol Biol, Lab Struct Biol & Mol Med, Los Angeles, CA 90095 USA
关键词
D O I
10.1021/bi000953+
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We analyzed the propensity of the HER3 receptor and its extracellular domain (ECD) to undergo ligand-independent self-association. The HER3-ECD, purified from Drosophila S2 cells, binds the EGF-like domain of heregulin (hrg) with a Kd of 1.9 nM as measured by surface plasmon resonance (SPR) studies. In a gel shift assay, the HER3-ECD self-associates into a uniform, slowly migrating species in a concentration-dependent manner, starting at concentrations of <10 nM. In contrast to the HER3-ECD, the ECD from the related HER2 receptor does not oligomerize under the same conditions. The direct interaction of HER3-ECDs was also demonstrated by pull-down assays and SPR measurements under physiological salt conditions. This self-association of the HER3-ECD was reversed by the addition of hrg but not by EGF. The apparent equilibrium dissociation constant for the HER3-ECD self-association is 15 nM, based on SPR measurements. In this analysis, hrg blocks HER3-ECD self-association, and the addition of hrg during the dissociation phase resulted in an accelerated off rate. This finding suggests that hrg can bind to and disrupt preexisting HER3-ECD oligomers. Full-length HER3 likewise exhibited self-association. Under conditions where co-immunoprecipitation and cross-linking of HER2 and HER3 were stimulated by hrg, HER3 self-association and cross-linking were disrupted by hrg. The implication is that the self-association of HER3-ECD favors the formation of catalytically inactive complexes of the HER3 receptor. Binding of hrg releases HER3 which may then form signaling-competent HER3-HER2 heterodimers.
引用
收藏
页码:8503 / 8511
页数:9
相关论文
共 40 条
[1]   Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells [J].
Aguilar, Z ;
Akita, RW ;
Finn, RS ;
Ramos, BL ;
Pegram, MD ;
Kabbinavar, FF ;
Pietras, RJ ;
Pisacane, P ;
Sliwkowski, MX ;
Slamon, DJ .
ONCOGENE, 1999, 18 (44) :6050-6062
[2]   AMPLIFICATION OF C-ERBB-2 AND AGGRESSIVE HUMAN-BREAST TUMORS [J].
ALI, IU ;
CAMPBELL, G ;
LIDEREAU, R ;
CALLAHAN, R .
SCIENCE, 1988, 240 (4860) :1795-1796
[3]  
ALIMANDI M, 1995, ONCOGENE, V10, P1813
[4]   MOLECULAR-WEIGHTS OF GLYCOSYLATED AND NONGLYCOSYLATED FORMS OF RECOMBINANT HUMAN STEM-CELL FACTOR DETERMINED BY LOW-ANGLE LASER-LIGHT SCATTERING [J].
ARAKAWA, T ;
LANGLEY, KE ;
KAMEYAMA, K ;
TAKAGI, T .
ANALYTICAL BIOCHEMISTRY, 1992, 203 (01) :53-57
[5]   Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display [J].
Ballinger, MD ;
Jones, JT ;
Lofgren, JA ;
Fairbrother, WJ ;
Akita, RW ;
Sliwkowski, MX ;
Wells, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (19) :11675-11684
[6]  
Baulida J, 1996, J BIOL CHEM, V271, P5251
[7]  
CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303
[8]  
CHINKERS M, 1992, J BIOL CHEM, V267, P18589
[9]   INTERACTION OF THE NEU P185 AND EGF RECEPTOR TYROSINE KINASES - IMPLICATIONS FOR CELLULAR-TRANSFORMATION AND TUMOR-THERAPY [J].
DOUGALL, WC ;
QIAN, XL ;
GREENE, MI .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, 53 (01) :61-73
[10]   HETERODIMERIZATION AND FUNCTIONAL INTERACTION BETWEEN EGF RECEPTOR FAMILY MEMBERS - A NEW SIGNALING PARADIGM WITH IMPLICATIONS FOR BREAST-CANCER RESEARCH [J].
EARP, HS ;
DAWSON, TL ;
LI, X ;
YU, H .
BREAST CANCER RESEARCH AND TREATMENT, 1995, 35 (01) :115-132